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Abstract. Conversational Agents (CAs) are software programs that replicate hu-
man conversations using machine learning (ML) and natural language processing 
(NLP). CAs are currently being utilised for diverse clinical applications such as 
symptom checking, health monitoring, medical triage and diagnosis. Intent clas-
sification (IC) is an essential task of understanding user utterance in CAs which 
makes use of modern deep learning (DL) methods. Because of the inherent model 
uncertainty associated with those methods, accuracy alone cannot be relied upon 
in clinical applications where certain errors may compromise patient safety. In 
this work, we employ Bayesian Long Short-Term Memory Networks (LSTMs) 
to calculate model uncertainty for IC, with a specific emphasis on symptom 
checker CAs. This method provides a certainty measure with IC prediction that 
can be utilised in assuring safe response from CAs. We evaluated our method on 
in-distribution (ID) and out-of-distribution (OOD) data and found mean uncer-
tainty to be much higher for OOD data. These findings suggest that our method 
is robust to OOD utterances and can detect non-understanding errors in CAs.  
Keywords: Conversational Agents (CAs), Machine Learning, Model Uncer-
tainty, Out-of-Distribution (OOD), Healthcare, Patient Safety. 
1 Introduction 
Conversational Agents (CAs) such as Google Home and Amazon Alexa are interactive 
conversational systems that use Machine Learning (ML) to respond to the user in nat-
ural language via voice or text [1]. They can be categorised into two types: task-oriented 
CAs [2] and chatbots [3]. In healthcare studies, task-oriented CAs are often utilised as 
they are focused on achieving a task such as booking a consultation or finding a hospi-
tal. Chatbots are systems designed for open-ended conversations and mimic unstruc-
tured conversations or chats. Common applications of CAs in healthcare include symp-
tom checking [4], chronic disease management [5], health monitoring and medication 
adherence [6].  
CAs employ a pipeline architecture [7] as shown in Figure 1. The fundamental com-
ponents in this architecture are Natural Language Understanding (NLU) and Dialog 
Manager (DM) which enable their understanding and decision making. The user then 
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receives the response proposed by DM via the Natural Language Generation (NLG) 
module. In this pipeline architecture, the NLU maps user utterances to intents and slots 
and has a significant impact on downstream processing. NLU errors may lead to erro-
neous decision making [8], which can be costly in healthcare because of the risk to 
human life and ethical issues [9]. Specifically, the NLU in CAs is concerned with the 
IC and slot-filling (SF) [7]. IC predicts a user’s intent from a given utterance, and it is 
a classification problem of identifying the correct intent label. SF in NLU extracts ad-
ditional information needed to accomplish the user’s task. For example, a user asking 
a CA “show me nearby hospitals” could have ‘show_hospital’ as intent and the current 
user location as the slot value. 
 
 
Figure 1: Conversational Agent (CA) Architecture 
DL have allowed significant performance enhancements in computer vision and Nat-
ural Language Processing (NLP) tasks and their variants such as Recurrent Neural Net-
works (RNNs) [10, 11] and Long Short-Term Memory Networks (LSTMs) [12] are 
commonly used for IC in CAs. These networks are able to attain higher accuracy on 
text classification tasks as they are better suited to model time series data.  
Existing state-of-the-art Deep learning (DL) methods are prone to data and model 
uncertainties [13]. Model uncertainty, also known as epistemic uncertainty, occurs be-
cause of the reliance of the model on training data for their prediction. This uncertainty 
can be reduced by providing enough training data. Estimating model uncertainty is ex-
tremely crucial also because of the difficulty to obtain high-quality datasets in 
healthcare [14]. In addition, it is almost impossible to provide complete data as DL 
models will always reflect an imperfect representation of the real world [15].  
In general, for classification problems, the softmax function is utilised by DL models 
at the output, resulting in a probability distribution over class labels. The label with the 
highest probability is then chosen as the prediction. The softmax function calculates 
relative probabilities between classes but does not provide a measure of the model’s 
uncertainty [16]. The probabilistic nature of softmax output is one of the reasons this 
score cannot be used as a confidence measure of the model in its prediction. DL models 
on unseen data tend to make predictions with the high softmax values and thus it is 
undesirable to use them in safety-critical systems [17]. 
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CAs are vulnerable to failures in understanding user utterance, and non-understand-
ing errors are one of those failures [18]. Non-understanding errors arise when the sys-
tem is unable to understand user input due to the system's inability to support the re-
quested feature or poorly formatted input. For example, a user asking a COVID symp-
tom checking CA about diabetes symptoms would result in a non-understanding error. 
Similarly, any unknown or incorrect input would also cause a non-understanding error. 
A common source of non-understanding errors is out-of-distribution (OOD) data [19]. 
Non-understanding errors usually result in poor user experience and may not be desir-
able to have them in safety-critical applications. As described earlier, the way DL mod-
els make predictions and are inherently uncertain, the need to detect non-understanding 
errors is significant in CAs that utilise DL methods. 
Bayesian modelling techniques provide a probabilistic representation of model un-
certainty but these usually are computationally expensive [16]. It is however possible 
to interpret DL methods as Bayesian models without modifying the model to reduce 
this computational complexity [20]. DL methods suffer from overfitting with limited 
training examples and dropouts are utilised during training time to prevent it. Addition-
ally, these dropouts can be used at test time to generate random predictions which are 
sampled out to interpret in a probabilistic manner. This technique is known as Monte-
Carlo (MC) dropout [16]. In this work, we apply Bayesian method to model LSTM for 
IC which enables us to quantify model uncertainty, thus enhancing confidence in 
model’s decisions during IC.  
The key contributions of this paper are: 
1. We utilise Bayesian LSTM with MC dropout for computing uncertainty in IC for 
CAs.  
2. A symptom checking prototype CA is designed to demonstrate the importance of 
robust IC in CAs and how our method can be utilised for assuring safe response. 
3. We evaluate our approach using an OOD evaluation dataset and compare the results 
to ID data.   
2 Related Work 
IC methods in CAs range from rule-based to ML approaches, but the state-of-art in 
IC use DL methods which include RNNs and LSTMs [10, 21]. Westhuizen et al. [22] 
show the utility of Bayesian LSTMs on medical time series data using MC dropout and 
concluded their performance enhancements over standard LSTMs. They utilised MC 
dropout for 100 Bayesian LSTM samples and found that using it during test time en-
hanced performance on all datasets and provided the added benefit of having a confi-
dence measure alongside the predicted class. Dusenberry et al. [9] investigated several 
strategies to analyse model uncertainty for electronic health records. In comparison to 
ensemble RNNs, Bayesian RNNs performed better while only requiring training a sin-
gle model. These authors concluded that Bayesian RNNs are more efficient, making 
them better suited for use in medical domain.  
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Other studies in healthcare involving deep neural networks (DNNs) have employed 
MC dropout to approximate uncertainty for classification tasks [23, 24]. These, how-
ever, make use of image data to estimate uncertainty. This method is also used in other 
safety-critical domains such as autonomous vehicles (AV), to estimate uncertainty for 
the AV to make safe decisions such as decelerate to speed limit or brake to stop driving 
[25].  
The use of Bayesian approach, in addition to providing confidence in the decision of 
the model, enables us to detect non-understanding errors in CAs. As mentioned already, 
OOD data is one of the sources of these errors. It is critical to correctly identify OOD 
data in NLU to avoid DM taking an incorrect action [26] which could be catastrophic. 
Common approaches used for OOD detection rely on a threshold measure, which is 
subsequently utilised to compute a detection score using various methods. Bayesian 
models [27], and classifier ensembles [28] are two of these approaches. However, these 
approaches are computationally expensive, which limits their utility in industrial set-
tings. 
Another method for determining OOD detection is to use the highest softmax value 
as the detection score. However, as recent research has demonstrated [16], the softmax 
value is not a credible indication of the model’s confidence. Other approaches rely on 
OOD labels with training examples [29], which is not viable since we cannot estimate 
how many OOD samples are necessary for training a model. A few studies [30, 31] 
have relied on OOD data creation to boost detection scores. This necessitates the crea-
tion of OOD samples for detection and reliance on tagged instances, which is an addi-
tional step in OOD detection process. 
In [22],  MC dropout for classification was utilised using medical data for image and 
speech datasets. Unlike the work in [22], we employed text data for our classification 
of medical time series data and analysed the impact of misclassification on patient 
safety by presenting a use case of symptom checking CA. In addition, we validate our 
method on an evaluation dataset designed for OOD data [26] which is also used in other 
studies [31]. We perform a comparison of results of uncertainty estimation between ID 
and OOD data which is discussed in detail in the Results section. 
3  Methods 
We employ Bayesian LSTM as part of our RNN architecture for the IC model of NLU. 
MC dropout [16], which is used at test time is then utilised to evaluate model uncer-
tainty for IC. We designed a use case and implemented a prototype CA that performs 
symptom checking on medical data. In this use case, we are concerned with how un-
certainty estimation in IC in CAs can aid in assuring safe response.   
3.1 Bayesian LSTM 
Bayesian implementation of LSTM allows us to estimate model uncertainty, which in-
dicates our imperfect understanding of the model’s underlying parameters. Dropout at 
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test time allows us to approximate the variational posterior distribution of model pa-
rameters (weights and biases). Using random dropout, we can sample different model 
parameters of this posterior distribution. By introducing a distribution over all model 
parameters, different functions can be induced. Through the realisation of distinct 
model parameter values selected from the posterior distribution, these functions lead to 
varied outcomes. The softmax predictions from each of these sampled parameters are 
averaged for new data. This allows us to have increased confidence in the softmax pre-
diction. The softmax class prediction is then used to estimate model uncertainty in the 
form of Shannon entropy [31]. 
Table 1 shows the architecture of the Bayesian LSTM we utilise for our IC model. 
We implemented a Bayesian LSTM layer referred to as ‘MCLSTM’, which allows us 
to employ the same dropout mask during test time at each time step of recurrent layers 
of LSTM [20]. A dropout rate of 70% was utilised to estimate model uncertainty. The 
hyperparameter, dropout, at this percentage produced the best model accuracy and ro-
bust model uncertainty. We apply MC dropout after the dense layer allowing us to cap-
ture the model uncertainty for the dense layers as well. 
Table 1: Recurrent Neural Network Architecture 
Layer Output Shape Parameters 
Input Layer (None, 30) 0 
Embedding (None, 30, 50) 5000000 
MCLSTM (None, 64) 29440 
Dense Layer (None, 256) 16640 
Activation (None, 256) 0 
Dropout (None, 256) 0 
Dense Layer (None, 25) 6425 
Activation (None, 25) 0 
3.2 Symptom Checker Use Case 
We present a symptom checking CA prototype to highlight the impact of incorrect IC 
on patient safety and how our method can aid in providing a safe response when the 
model is uncertain about its prediction. As an example, during the current COVID-19 
pandemic, many web and mobile-based applications were developed for the general 
public to check if they have COVID symptoms [32]. The reliability of the decisions 
made by these diagnostic systems can not solely rely on their accuracy [9] and this also 
holds for clinicians making their decisions [33]. From the clinical safety perspective, a 
calibration of confidence and accuracy is important. 
The architecture of our prototype CA is shown in Figure 2. The input text utterance 
is provided by the user, which is handled by the NLU and IC is performed using Bayes-
ian LSTM. In the case where the NLU is not certain about the prediction, a safe strategy 
(asking the user to rephrase or connecting the user to a human clinician) can be utilised 
before the NLU result is passed to the DM. 
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Figure 2: Symptom checker use case CA architecture diagram 
We utilise an open-source dataset [34] to train our Bayesian LSTM model for un-
derstanding. The dataset contains 6661 text utterances of common medical symptoms 
like “knee pain”, or “headache”. The dataset contains 25 distinct intents which are 
evenly distributed across the dataset as shown in Figure 3. We pre-process the dataset 
by performing case normalization and removing punctuations and white spaces. After 
the pre-processing step, the utterances are padded to be of equal length. To use the data, 
we then transform the text utterances to numerical data using one-hot encoding scheme. 
We use an 85:15 ratio to split the dataset into training and testing, which turns our 
training size to 5661 and the test size to 1000 utterances. 
 
 
Figure 3: The distribution of medical symptoms in the dataset 
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4 Results 
Our model utilising Bayesian LSTM achieved an accuracy of 99.4% on the test dataset. 
Figure 4 shows the confusion matrix which reflects the model’s high accuracy. The y-
axis lists the actual symptoms, and the x-axis lists the predicted symptoms by the model. 
Due to the higher accuracy, there are very few misclassifications by the model. 
 
 
Figure 4: Confusion matrix of symptoms classification 
Table 2 summarises the average findings for each of the medical symptoms (intents) 
in the dataset by the following evaluation metrics: precision, recall, and F1-score. The 
number of samples for each intent is represented by the “Support” column, which in-
dicates that there is no class imbalance in the test set. Because of their increased accu-
racy, these evaluation metrics appear to indicate near-perfect scores for each of the in-
tents. The precision and recall usually do not provide a good measure of the quality of 
the model as they can be high because of class imbalance. The F1-score provides a 
weighted average of both the precision and recall and in our experiment, it also achieves 
a near 100% score for most of the intents which is an indication of good model perfor-
mance. The average metrics (macro and weighted average) scores indicate that there is 
very little class imbalance which validates the high accuracy on the test set. 
 We sample the softmax value for the same input 100 times to calculate the uncer-
tainty. This yields the output posterior distribution for softmax values, which is then 
averaged, and the entropy for all outputs is calculated. A higher entropy value reflects 
high uncertainty which indicates the possibility of the input from OOD data [31]. Table 
3 lists the ID utterances randomly selected from the test dataset, predictions, and their 
entropy calculations. The model correctly predicts all the utterances which is due to the 
higher model accuracy and ID nature of utterances.  
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Table 2: Average evaluation metrics for medical symptoms 
Medical Symptoms Precision Recall F1-Score Support 
acne 1.000 1.000 1.000 52 
back pain 1.000 1.000 1.000 28 
blurry vision 1.000 1.000 1.000 43 
body feels weak 1.000 1.000 1.000 37 
cough 1.000 1.000 1.000 45 
ear ache 1.000 1.000 1.000 38 
emotional pain 1.000 1.000 1.000 38 
feeling cold 1.000 1.000 1.000 39 
feeling dizzy 1.000 1.000 1.000 42 
foot ache 0.971 1.000 0.986 34 
hair falling out 1.000 1.000 1.000 40 
hard to breath 1.000 1.000 1.000 25 
head ache 1.000 1.000 1.000 48 
heart hurts 0.971 1.000 0.986 34 
infected wound 0.980 1.000 0.990 48 
injury from sports 1.000 1.000 1.000 27 
internal pain 0.921 0.972 0.946 36 
joint pain 1.000 1.000 1.000 52 
knee pain 1.000 1.000 1.000 44 
muscle pain 1.000 0.974 0.987 38 
neck pain 1.000 1.000 1.000 43 
open wound 1.000 1.000 1.000 34 
shoulder pain 1.000 1.000 1.000 51 
skin issue 1.000 0.971 0.985 34 
stomach ache 1.000 0.940 0.969 50 
accuracy 0.994 0.994 0.994 0.994 
macro avg 0.994 0.994 0.994 1000 
weighted avg 0.994 0.994 0.994 1000 
 
Table 3: Uncertainty estimation for in-distribution (ID) utterances 
Test Utterance (ID) Prediction Entropy 
my head is so heavy cant think normally head ache 0.029 
i feel a burning sensation in my shoulder muscle muscle pain 0.055 
i can hardly breathe hard to breath 0.071 
i have internal pain whenever i come down with   a 
cold 
internal pain 0.327 
when i’m awake in the morning i feel strange and 
have vertigo 
feeling dizzy 0.507 
9 
Table 4: Uncertainty estimation for out of distribution (OOD) utterances 
Test Utterance (OOD) Prediction Entropy 
am i connected to wifi feeling cold 1.057 
how much time do i have left on my 0 apr shoulder pain 1.110 
what casino game has the best odds injury from sports 1.862 
please alert me when my iphone battery 
falls below 30 
neck pain 2.134 
what is the warranty on my microwave skin issue 2.302 
 
Table 4 shows the five random utterances from OOD dataset [26] with model pre-
diction and entropy calculations. This dataset contains 1000 utterances for evaluation 
purpose and differs from the dataset on which the IC model is trained. As shown in 
Figure 5, the mean entropy for this OOD dataset for an identical number of samples is 
2.025 which is substantially higher than the mean entropy of 0.098 for ID utterances. 
This demonstrates that our method can be utilised to detect non-understanding errors 
as well as to help assure the safety of CA response in the wake of uncertainty from DL 
models. 
 
Figure 5: Entropy calculations for ID (top) and OOD (bottom) data 
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5 Discussion 
Our model based on Bayesian LSTM yielded high accuracy of 99.4% on the test da-
taset. The training dataset examples contained low class imbalance and we applied 
dropout during training to improve model performance. The use of MC dropout at test 
time enabled us to sample multiple outputs and we calculated entropy by averaging out 
100 samples from this distribution. It is worth noting that the classifier in this case even 
having near 100% accuracy cannot be trusted from their prediction alone which we 
discussed earlier. As seen in Table 4, for all OOD utterances the prediction was incor-
rect with high uncertainty. The average model entropy for ID data (test dataset) was 
much lower than the average entropy for OOD data with the same number (1000) of 
examples. It is yet to be seen if this pattern continues for a very large number of OOD 
data.  
 The state-of-art in CAs rely on DL methods [10] which are prone to uncertainties in 
their decisions [35]. In healthcare, instead of making wrong predictions, these models 
should be able to say “sorry, I don’t know” when they are uncertain.  From our findings 
on OOD of relatively small size (1000 samples), the entropy measure can be utilised to 
know when a model is uncertain in its decision. We present a use case of symptom 
checking where this method during IC can be useful for providing a safe response. A 
safety monitor such as one discussed in [36] may be deployed after NLU output which 
can filter high uncertainty inputs to avoid any incorrect actions by the DM. Alterna-
tively, as mentioned in [37], a user may be asked to provide a rephrase input. In case of 
high uncertainty, another approach of handing over the control to a human clinician 
may also be used [38]. 
6 Conclusion and Future Work 
In this paper, we presented a robust mechanism for IC in clinical CAs by measuring 
model uncertainty using Bayesian LSTMs. A symptom checking prototype CA was 
implemented to illustrate the benefit of certainty measure alongside prediction. This 
method shows that non-understanding errors in CAs can be avoided and a safety 
strategy (safety monitor in CA architecture, or human involvement) can be utilised to 
prevent unsafe responses. We evaluated our approach on a dataset of 1000 samples and 
the results were promising. However, further research may be required to estimate the 
minimum data required for this method. Additionally, data uncertainty [35] which 
occurs due to noise in the data may require to be calculated for the assurance of safe 
response in CAs.  
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